Experience. Commitment. Results.
Stemline Therapeutics, Inc. (STML) related to its sale to Berlin-Chemie AG. Under the terms of the agreement, Stemline shareholders will have the right to receive (i) $11.50 in cash plus (ii) one contingent value right for each share of Stemline common stock owned.
resTORbio, Inc. (TORC) relating to the combination with Adicet Bio, Inc. Under the terms of the agreement, Adicet shareholders are expected to own approximately 75% of the combined company and resTORbio shareholders are expected to own 25%.
Asta Funding, Inc. (ASFI) relating to its sale to Asta Finance Acquisition Inc. Under the terms of the agreement, Asta Funding shareholders shall be entitled to receive $11.47 in cash for each share of Asta Funding common stock owned.
Standard Diversified Inc. (SDI) relating to its sale to Turning Point Brands, Inc (“TPB”). Under the terms of the agreement, each share of SDI Class A and Class B common stock will be converted into the right to receive a ratio of 0.97 of TPB Voting common stock for each share of TPB common stock … Read more
SB One Bancorp (SBBX) relating to its sale to Provident Financial Services, Inc. Under the terms of the agreement, each share of SB One common stock will be converted into the right to receive 1.357 share of Provident common stock for each SB One common stock owned.
Tetraphase Pharmaceuticals, Inc. (TTPH) relating to its sale to AcelRx Pharmaceuticals, Inc. Under the terms of the agreement, each share of Tetraphase common stock will be converted into the right to receive 0.6303 of AcelRx common stock for each Tetraphase common stock owned.
TerraForm Power, Inc. (TERP) relating to its sale to Brookfield Renewable Power. Under the terms of the agreement, TerraForm shareholders will receive 0.381 of Brookfield Renewable units for each share of TerraForm common stock owned.
AVX Corporation (AVX) relating to its sale to Kyocera Corporation. Under the terms of the agreement, AVX shareholders will receive $21.75 for each share of AVX common stock owned.
QIAGEN N.V. (QGEN) related to its combination to Thermo Fisher Scientific Inc (“TMO”). Under the terms of the agreement, each share of QGEN will be purchased by TMO at a price of 39 Euros in cash for each QGEN common stock owned.
Willis Towers Watson PLC (WLTW) relating to its combination with Aon plc. Under the terms of the agreement, Willis Towers shareholders will be entitled to receive 1.08 newly issued Class A ordinary Aon share for each ordinary share of Willis Towers common stock owned.